Haploidentical Versus Matched Unrelated Donor Transplants Using Post-Transplantation Cyclophosphamide for Lymphomas
Transplant Cell Ther. 2023 Mar;29(3):184.e1-184.e9. doi: 10.1016/j.jtct.2022.11.028.…
An Analysis of the Worldwide Utilization of Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia
Transplant Cell Ther. 2023 Apr;29(4):279.e1-279.e10. doi: 10.1016/j.jtct.2022.12.013.…
Glofitamab for Relapsed or Refractory Diffuse Large B-Cell Lymphoma
N Engl J Med. 2022 Dec 15;387(24):2220-2231. doi: 10.1056/NEJMoa2206913.…
Front-line fludarabine-cyclophosphamide-rituximab (FCR) in 110 patients with chronic lymphocytic leukaemia (CLL): real-life experience with long-term outcomes, toxicities and responses to second-line therapies
Int J Hematol. 2023 Mar;117(3):388-397. doi: 10.1007/s12185-022-03488-5.…
NGS-Based Molecular Karyotyping of Multiple Myeloma: Results from the GEM12 Clinical Trial
Cancers (Basel). 2022 Oct 21;14(20):5169. doi: 10.3390/cancers14205169.ABSTRACTNext-generation…
The importance of the clinical classification of adult T-cell leukemia/lymphoma (ATLL) in the prognosis
PLoS Negl Trop Dis. 2022 Oct 19;16(10):e0010807. doi: 10.1371/journal.pntd.0010807.…
A phase 1/2, open-label, multicenter study of isatuximab in combination with cemiplimab in patients with lymphoma
Hematol Oncol. 2023 Feb;41(1):108-119. doi: 10.1002/hon.3089.…
Access to and affordability of CAR T-cell therapy in multiple myeloma: an EBMT position paper
Lancet Haematol. 2022 Oct;9(10):e786-e795. doi: 10.1016/S2352-3026(22)00226-5.ABSTRACTChimeric…
Editorial: Novel treatments for diffuse large B-cell lymphoma: The post-CART era
Front Immunol. 2022 Aug 8;13:1002615. doi: 10.3389/fimmu.2022.1002615.…
Best Treatment Option for Patients With Refractory Aggressive B-Cell Lymphoma in the CAR-T Cell Era: Real-World Evidence From GELTAMO/GETH Spanish Groups
Front Immunol. 2022 Jul 12;13:855730. doi: 10.3389/fimmu.2022.855730.…
Novel Endometrial Cancer Models Using Sensitive Metastasis Tracing for CXCR4-Targeted Therapy in Advanced Disease
Biomedicines. 2022 Jul 12;10(7):1680. doi: 10.3390/biomedicines10071680.ABSTRACTAdvanced…
Liquid biopsy for disease monitoring after anti-CD19 chimeric antigen receptor T cell in diffuse large B-cell lymphoma
EJHaem. 2020 Dec 9;2(1):109-111. doi: 10.1002/jha2.131. eCollection…
